Android app on Google Play

Obagi Medical Products, Inc. (OMPI) Tops Q4 EPS by 5c

March 8, 2012 4:11 PM EST Send to a Friend
Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q4 EPS of $0.24, $0.05 better than the analyst estimate of $0.19. Revenue for the quarter came in at $30.6 million versus the consensus estimate of $30.64 million.

For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment